-
-
[1] Ustianowski AP, Sieu TP, Day JN. Penicilliummarneffei infection in HIV[J]. Curr Opin Infect Dis, 2008, 21: 31-36. doi: 10.1097/QCO.0b013e3282f406ae [2] Hu Y, Zhang J, Li X, et al.Penicilliummarneffei infection: an emerging disease in mainland China[J]. Mycopathologia, 2013, 175: 57-67. doi: 10.1007/s11046-012-9577-0 [3] Vanittanakom N, Sirisanthana T. Penicilliummarneffei infection in patients infected with human immunodeficiency virus[J]. Curr Top Med Mycol, 1997, 8: 35. [4] Kawila R, Chaiwarith R, Supparatpinyo K. Clinical and laboratory characteristics of penicilliosismarneffei among patients with and without HIV infection in Northern Thailand: a retrospective study[J]. BMC Infect Dis, 2013, 13:464. doi: 10.1186/1471-2334-13-464 [5] Gugnani H, Fisher MC, Paliwal-Johsi A, et al. Role of Cannomysbadius as a natural animal host of Penicilliummarneffei in India[J].J Clin Microbiol, 2004, 42: 5070-5075. doi: 10.1128/JCM.42.11.5070-5075.2004 [6] 黄丽芬, 唐小平, 蔡卫平, 等.广东地区762例住院人类免疫缺陷病毒感染患者机会性感染分析[J].中华内科杂志, 2010, 49:653- 656. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhnk201008006 [7] Zhou F, Bi X, Zou X, et al.Retrospective analysis of 15 cases of Penicilliosismarneffei in a southern China hospital[J].Mycopathologia, 2014, 177:271-279. doi: 10.1007/s11046-014-9737-5 [8] 张建全, 杨美玲, 钟小宁, 等.人免疫缺陷病毒抗体阴性与阳性者播散性马尔尼菲青霉菌病的临床及实验室特征[J].中华结核和呼吸杂志, 2008, 31:740-746. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhjhhhx200810009 [9] 焦洋, 范洪伟, 王澎, 等.第379例皮疹-发热-多发骨痛[J].中华医学杂志, 2016, 96:3178-3181. [10] Qiu Y, Zhang J, Liu G, et al.A case of penicilliummarneffei infection involving the main tracheal structure[J]. BMC Infect Dis, 2014, 14:242. doi: 10.1186/1471-2334-14-242 [11] Qiu Y, Pan M, Zhang J, et al. Two Unusual Cases of Human Immunodeficiency Virus-Negative Patients with Talaromyces marneffei Infection. [J]. Am J Trop Med Hyg, 2016, 95:426-430. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=8ec3c828f202d126fd588893f7ee2352 [12] Cheng VC, Yam WC, Woo PC, et al.Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients[J]. Eur J Clin Microbiol Infect Dis, 2003, 22:597-602. doi: 10.1007/s10096-003-0998-z [13] Sirisanthana T, Supparatpinyo K. Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients[J]. Int J Infect Dis, 1998, 3:48-53. doi: 10.1016/S1201-9712(98)90095-9 [14] 王艳芳, 曾磊, 陈学东, 等.双抗原夹心ELISA法检测马尔尼菲青霉Mp1p抗体[J].南方医科大学学报, 2013, 33:439-443. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=dyjydxxb201303028 [15] Lu S, Li X, Calderone R, et al. Whole blood Nested PCR and Real-time PCR amplification of Talaromyces marneffei specific DNA for diagnosis[J]. Med Mycol, 2016, 54:162-168. doi: 10.1093/mmy/myv068 [16] Ranjana KH, Priyokumar K, Singh TJ, et al. Disseminated Penicilliummarneffei infection among HIV-infected patients in Manipur state, India[J]. J Infect, 2002, 45:268. doi: 10.1053/jinf.2002.1062 [17] Sirisanthana T, Supparatpinyo K, Perriens J, et al. Amphotericin B and itraconazole for treatment of disseminated Penicilliummarneffei infection in human immunodeficiency virus-infected patients[J]. Clin Infect Dis, 1998, 26:1107-1110. doi: 10.1086/520280 [18] Supparatpinyo K, Schlamm HT. Voriconazole as therapy for systemic Penicilliummarneffei infections in AIDS patients[J]. Am J Trop Med Hyg, 2007, 77:350-353. doi: 10.4269/ajtmh.2007.77.350 [19] Cao C, Liu W, Li R, et al.In vitro interactions of micafungin with amphotericin B, itraconazole or fluconazole against the pathogenic phase of Penicilliummarneffei[J]. J Antimicrob Chemother, 2009, 63:340-342. [20] Mo D, Li X, Wei L, et al.In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicilliummarneffei[J]. Mycopathologia, 2014, 178:217-220. doi: 10.1007/s11046-014-9787-8
点击查看大图
计量
- 文章访问数: 255
- HTML全文浏览量: 29
- PDF下载量: 68
- 被引次数: 0